98%
921
2 minutes
20
The exploration of natural products as lead scaffolds continues to serve as a valuable strategy for the development of novel antifungal agents. In this investigation, we focused on the natural furanoid compound 2-heptyl-5-hexylfuran-3-carboxylic acid (HHCA) and designed and synthesized four distinct series of multisubstituted furan carboxylic acid derivatives. Comprehensive structural characterization and biological evaluation were performed for all 48 compounds. In vitro antifungal screening against eight prevalent plant pathogens revealed that some of these derivatives exhibited significant inhibitory effects against and . Structure-activity relationship analysis demonstrated that peptide-containing derivatives showed superior antifungal potency compared with their hydrazide, amide, and ester counterparts. The most promising candidate compound was further evaluated for its in vivo efficacy against two plant pathogens, and , indicating potent antifungal activity with EC values of 17.14 μg/mL and 19.63 μg/mL, respectively. Notably, these values were significantly lower than those of the natural product HHCA with an enhanced antifungal potency. These findings highlight the practical potential of compound as a novel antifungal agent for agricultural applications. Mechanistic investigations employing microscopic analysis, molecular docking simulations, and density functional theory (DFT) calculations provided insights into the putative mode of action of , particularly regarding its interaction with succinate dehydrogenase (SDH). These findings establish a foundation for the rational development of HHCA-derived furan derivatives as novel SDH-targeting fungicidal agents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.jafc.4c12584 | DOI Listing |
J Agric Food Chem
June 2025
Key Lab of Microbial Pesticides (Ministry of Agriculture and Rural Affairs), National Biopesticide Engineering Research Centre, Hubei Biopesticide Engineering Research Centre, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
The exploration of natural products as lead scaffolds continues to serve as a valuable strategy for the development of novel antifungal agents. In this investigation, we focused on the natural furanoid compound 2-heptyl-5-hexylfuran-3-carboxylic acid (HHCA) and designed and synthesized four distinct series of multisubstituted furan carboxylic acid derivatives. Comprehensive structural characterization and biological evaluation were performed for all 48 compounds.
View Article and Find Full Text PDFEur Radiol
May 2025
University Medical Imaging Toronto, University Health Network, University of Toronto, Toronto, ON, Canada.
Objective: To assess qualitative and quantitative imaging features, including lesion-to-liver contrast enhancement ratio (LLCER), on gadoxetic acid-enhanced MRI for differentiating atypical focal nodular hyperplasia (aFNH) from hepatocellular adenoma (HCA) subtypes.
Materials And Methods: This retrospective study included patients with histopathologically-confirmed aFNH and HCA who underwent gadoxetic acid-enhanced MRI between January 2010 and December 2020. Two radiologists assessed qualitative imaging features and calculated LLCERs for quantitative evaluation of HBP enhancement.
Zhonghua Gan Zang Bing Za Zhi
November 2023
Department of Radiology, Zhongshan Hospital, Fudan University; Department of Radiology, Shanghai Geriatric Medical Center, Shanghai 200032, China.
To investigate the MRI imaging features of hepatocyte nuclear factor 1α- inactivated hepatocellular adenoma (H-HCA). Clinical data and MRI images of 19 H-HCA cases who were pathologically confirmed at Zhongshan Hospital Affiliated to Fudan University between August 2014 and July 2020 were retrospectively analyzed. Among them, there were 15 females and 4 males, aged 16-47 (32± 7) years old.
View Article and Find Full Text PDFAJR Am J Roentgenol
January 2023
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065.
Accumulating evidence indicates that hepatocellular adenoma (HCA) may have a higher frequency of hepatobiliary phase (HBP) iso- or hyperintensity than previously reported. The purpose of this study was to evaluate the proportion of HCA that shows iso- or hyperintensity in the HBP of gadoxetic acid-enhanced MRI, stratified by HCA subtype (-inactivated [H-HCA], inflammatory [I-HCA], β-catenin-activated [B-HCA], and unclassified [U-HCA] HCA), and to assess the diagnostic performance of HBP iso- or hyperintensity for differentiating focal nodular hyperplasia (FNH) from HCA. PubMed, Embase, and Cochrane Central Register of Controlled Trials were searched through February 14, 2022, for articles reporting HBP signal intensity on gadoxetic acid-enhanced MRI among pathologically proven HCAs, stratified by subtype.
View Article and Find Full Text PDFHum Pathol
April 2022
Department of Pathology, University of California, San Francisco, CA, 94143, USA. Electronic address:
HNF1A-inactivated hepatocellular adenomas (H-HCA) show steatosis, no atypia and loss of liver fatty acid binding protein (LFABP). LFABP loss also occurs in hepatocellular carcinoma (HCC). This study examines 68 LFABP-negative tumors: 33 typical H-HCA, 10 atypical hepatocellular neoplasms (AHN), 7 well-differentiated (WD) HCC, 18 moderately or poorly differentiated (MD/PD) HCC.
View Article and Find Full Text PDF